# Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay

> **NCT06876571** · — · NOT_YET_RECRUITING · sponsor: **Invivoscribe, Inc.** · enrollment: 250 (estimated)

## Conditions studied

- T-Cell Lymphoproliferative Disorder

## Interventions

- **DIAGNOSTIC_TEST:** IdentiClone Dx TRG Assay

## Key facts

- **NCT ID:** NCT06876571
- **Lead sponsor:** Invivoscribe, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-06-02
- **Primary completion:** 2025-11-06
- **Final completion:** 2025-12-06
- **Target enrollment:** 250 (ESTIMATED)
- **Last updated:** 2025-03-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06876571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06876571, "Pivotal, Clinical Study for the Accuracy Evaluation of the IdentiClone Dx TRG Assay". Retrieved via AI Analytics 2026-06-04 from https://api.ai-analytics.org/clinical/NCT06876571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*